Comparative Pharmacology
Head-to-head clinical analysis: TENUATE DOSPAN versus TEPANIL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: TENUATE DOSPAN versus TEPANIL.
TENUATE DOSPAN vs TEPANIL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Releases norepinephrine from nerve terminals in the lateral hypothalamic feeding center, reducing appetite.
TEPANIL (diethylpropion) is a sympathomimetic amine that acts as a norepinephrine reuptake inhibitor in the hypothalamus, increasing norepinephrine levels in the synaptic cleft, which stimulates beta-2 adrenergic receptors, leading to appetite suppression.
25 mg orally three times a day, 1 hour before meals, or 75 mg extended-release orally once daily in the morning.
25 mg orally three times daily, 1 hour before meals, or 75 mg extended-release orally once daily in the morning.
None Documented
None Documented
The terminal elimination half-life is approximately 4-6 hours in adults with normal renal function, though clinical effects may last longer due to tissue distribution.
4-6 hours; clinical context: requires multiple daily dosing for sustained anorectic effect
Renal excretion of unchanged drug and metabolites; approximately 85-90% of the dose is excreted in urine within 48 hours, with less than 5% in feces.
Renal: 90% (as metabolites and unchanged drug), Fecal: <10%
Category C
Category C
Sympathomimetic anorectic
Sympathomimetic anorectic